Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake.
about
Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogsRestoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patientsInhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomersAntisense properties of tricyclo-DNAReceptor-mediated endocytosis of phosphodiester oligonucleotides in the HepG2 cell line: evidence for non-conventional intracellular trafficking.Identification, purification and partial characterisation of an oligonucleotide receptor in membranes of HepG2 cells.Intracellular Distribution and Nuclear Activity of Antisense Oligonucleotides After Unassisted Uptake in Myoblasts and Differentiated Myotubes In Vitro.Morphant technology in model developmental systems.Inhibition of zebrafish fgf8 pre-mRNA splicing with morpholino oligos: a quantifiable method for gene knockdown.Microenvironmental regulation of telomerase isoforms in human embryonic stem cellsEnhanced activity of antisense phosphorothioate oligos against leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions.mRNA transcript diversity creates new opportunities for pharmacological intervention.Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice.Therapeutic potential of splice-switching oligonucleotides.Exon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases.Using Morpholinos to Control Gene Expression.Oligonucleotide analogue interference with the HIV-1 Tat protein-TAR RNA interaction.Steric inhibition of human immunodeficiency virus type-1 Tat-dependent trans-activation in vitro and in cells by oligonucleotides containing 2'-O-methyl G-clamp ribonucleoside analogues.Morpholinos: studying gene function in the chick.Translational development of splice-modifying antisense oligomers.Temperature-dependent splicing of beta-globin pre-mRNA.An apparent pseudo-exon acts both as an alternative exon that leads to nonsense-mediated decay and as a zero-length exon.Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells.Using morpholinos to control gene expression.
P2860
Q24555118-9CE9FFD9-BB46-429A-BA83-AAD4749FDB88Q24670228-2C91727F-DF96-4121-B3F0-ABCE3D1CB931Q27486093-A2D8D6CF-E6BB-4312-8754-44D3E8265066Q31089384-56EA52A8-B99D-4733-825E-2F1E9AFB868BQ33601089-32D49FF6-5885-4CBE-A540-E6988C587594Q33614680-2A9FB711-4B73-4CA4-88A1-DE5D5C284405Q33786263-91862257-4A4C-4963-9F34-A335C9269525Q33953812-D91432F0-2ECD-4B05-AF7C-AF83B3CA05DAQ33953820-88E15889-6042-459C-8C3E-5C843917653EQ34081958-1D8C303C-6E6D-4D27-928F-5D34DC280DA3Q34904790-40B0D7B8-B446-4000-AEA5-2F39998F2913Q35913120-71B8AF77-6692-4166-8365-83E31F37BADEQ36316652-4DE83953-4FF6-4B25-8198-DBFAD2CD24AAQ37079038-89C49C40-F88A-4237-978A-704D1EF516F9Q37363171-8B2BC1BD-7F21-456F-ABF8-33EC4DBB187BQ38186137-2C274280-5CF5-4E18-BD24-24216CA2439DQ38288902-29E1EA80-F705-4AC6-ACDE-208E03AF7854Q38296788-3CFBD04A-6230-4026-A14B-3B6562F9908BQ38354184-8A20266B-3A9D-48C5-B566-9FB4F7687EA6Q38794231-E000FC36-B143-4BC2-AE25-8AAF019582B5Q38996657-D3778D10-D846-4223-A9F1-3C1EEBF59577Q39682226-CEA4F1A4-29C4-4F3E-9E63-80FFCF48495BQ43241157-F9B623B2-7849-4475-B018-F25E1A9DF5AFQ44960581-0D2A6B18-D2BA-4075-999E-ABC8FFEFB19FQ53481883-20B7075F-C3E5-4B33-AF6E-A9D1DF999AD2
P2860
Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Antisense oligonucleotides wit ...... thways and efficacy of uptake.
@en
type
label
Antisense oligonucleotides wit ...... thways and efficacy of uptake.
@en
prefLabel
Antisense oligonucleotides wit ...... thways and efficacy of uptake.
@en
P2093
P2860
P356
P1476
Antisense oligonucleotides wit ...... thways and efficacy of uptake.
@en
P2093
P2860
P304
21783-21789
P356
10.1074/JBC.274.31.21783
P407
P577
1999-07-01T00:00:00Z